Bisphosphonaterelated osteonecrosis of the jaw: A pictorial review

Radiographics

Volumn 29, Issue 7, 2009, Pages 1971-1984

  Morag, Yoav ^a   Morag Hezroni, Michal ^a   Jamadar, David A ^a   Ward, Brent B ^a   Jacobson, Jon A ^a   Zwetchkenbaum, Samuel R ^a   Helman, Joseph ^a  

^a UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; BONE DENSITY CONSERVATION AGENT;

BONE NECROSIS; CHEMICALLY INDUCED DISORDER; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; JAW DISEASE; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW;

BONE DENSITY CONSERVATION AGENTS; DIPHOSPHONATES; HUMANS; JAW DISEASES; MAGNETIC RESONANCE IMAGING; OSTEONECROSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77949890136     PISSN: 02715333     EISSN: 15271323     Source Type: Journal    
DOI: 10.1148/rg.297095050     Document Type: Article

References (29)

1. Raje N, Woo SB, Hande K, et al. Clinical, radiographic, and biochemical characterization of multiple myeloma patients with osteonecrosis of the jaw. Clin Cancer Res 2008;14(8):2387-2395.
2. Cheng A, Mavrokokki A, Carter G, et al. The dental implications of bisphosphonates and bone disease. Aust Dent J 2005;50(4 suppl 2):S4-S13.
3. Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 2003; 61(9):1115-1117.
4. Khosla S, Burr D, Cauley J, et al. Bisphosphonateassociated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 2007;22(10): 1479-1491.
5. American Association of Oral and Maxillofacial Surgeons. Position paper on bisphosphonate-related osteonecrosis of the jaw: 2009 update. Rosemont, Ill: American Association of Oral and Maxillofacial Surgeons, 2009.
6. Sambrook P, Olver I, Goss A. Bisphosphonates and osteonecrosis of the jaw. Aust Fam Physician 2006; 35(10):801-803.
7. Mavrokokki T, Cheng A, Stein B, Goss A. Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia. J Oral Maxillofac Surg 2007;65(3):415-423.
8. Novince CM, Ward BB, McCauley LK. Osteonecrosis of the jaw: an update and review of recommendations. Cells Tissues Organs 2009;189(1-4):275-283.
9. Hewitt C, Farah CS. Bisphosphonate-related osteonecrosis of the jaws: a comprehensive review. J Oral Pathol Med 2007;36(6):319-328.
10. Pazianas M, Miller P, Blumentals WA, Bernal M, Kothawala P. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics. Clin Ther 2007;29(8): 1548-1558.
11. Abu-Id MH, Warnke PH, Gottschalk J, et al. "Bisphossy jaws": high and low risk factors for bisphosphonate-induced osteonecrosis of the jaw. J Craniomaxillofac Surg 2008;36(2):95-103.
12. Durie BG, Katz M, Crowley J. Osteonecrosis of the jaw and bisphosphonates. N Engl J Med 2005;353 (1):99-102; discussion 99-102.
13. Reid IR, Cundy T. Osteonecrosis of the jaw. Skeletal Radiol 2009;38(1):5-9.
14. Huja SS, Fernandez SA, Hill KJ, Li Y. Remodeling dynamics in the alveolar process in skeletally mature dogs. Anat Rec A Discov Mol Cell Evol Biol 2006; 288(12):1243-1249.
15. Estilo CL, Van Poznak CH, Wiliams T, et al. Osteonecrosis of the maxilla and mandible in patients with advanced cancer treated with bisphosphonate therapy. Oncologist 2008;13(8):911-920.
16. Hansen T, Kunkel M, Springer E, et al. Actinomycosis of the jaws: histopathological study of 45 patients shows significant involvement in bisphosphonateassociated osteonecrosis and infected osteoradionecrosis. Virchows Arch 2007;451(6):1009-1017.
17. Marx RE, Sawatari Y, Fortin M, Broumand V. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 2005;63(11):1567-1575.
18. Reid IR, Bolland MJ, Grey AB. Is bisphosphonateassociated osteonecrosis of the jaw caused by soft tissue toxicity? Bone 2007;41(3):318-320.
19. Hansen T, Kunkel M, Weber A, James Kirkpatrick C. Osteonecrosis of the jaws in patients treated with bisphosphonates: histomorphologic analysis in comparison with infected osteoradionecrosis. J Oral Pathol Med 2006;35(3):155-160.
20. Bedogni A, Blandamura S, Lokmic Z, et al. Bisphosphonate-associated jawbone osteonecrosis: a correlation between imaging techniques and histopathology. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008;105(3):358-364.
21. Ruggiero SL, Fantasia J, Carlson E. Bisphosphonaterelated osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;102(4):433-441.
22. Bisdas S, Chambron Pinho N, Smolarz A, Sader R, Vogl TJ, Mack MG. Biphosphonate-induced osteonecrosis of the jaws: CT and MRI spectrum of findings in 32 patients. Clin Radiol 2008;63(1):71-77.
23. Bianchi SD, Scoletta M, Cassione FB, Migliaretti G, Mozzati M. Computerized tomographic findings in bisphosphonate-associated osteonecrosis of the jaw in patients with cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;104(2):249-258.
24. Catalano L, Del Vecchio S, Petruzziello F, et al. Sestamibi and FDG-PET scans to support diagnosis of jaw osteonecrosis. Ann Hematol 2007;86(6): 415-423.
25. Wutzl A, Eisenmenger G, Hoffmann M, et al. Osteonecrosis of the jaws and bisphosphonate treatment in cancer patients. Wien Klin Wochenschr 2006;118(15-16):473-478.
26. Store G, Larheim TA. Mandibular osteoradionecrosis: a comparison of computed tomography with panoramic radiography. Dentomaxillofac Radiol 1999;28(5):295-300.
27. Chiandussi S, Biasotto M, Dore F, Cavalli F, Cova MA, Di Lenarda R. Clinical and diagnostic imaging of bisphosphonate-associated osteonecrosis of the jaws. Dentomaxillofac Radiol 2006;35(4):236-243.
28. García-Ferrer L, Bagán JV, Martínez-Sanjuan V, et al. MRI of mandibular osteonecrosis secondary to bisphosphonates. AJR Am J Roentgenol 2008;190 (4):949-955.
29. Dore F, Filippi L, Biasotto M, Chiandussi S, Cavalli F, Di Lenarda R. Bone scintigraphy and SPECT/CT of bisphosphonate-induced osteonecrosis of the jaw. J Nucl Med 2009;50(1):30-35.